Risk factors for central venous catheter-related infections in pediatric intensive care

Clinics

Volumn 62, Issue 5, 2007, Pages 537-544

  Vilela, Ricardo ^a   Jácomo, Andréa D N ^a   Tresoldi, Antonia Teresinha ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Catheterization; Central venous; Child; Cross infection; Intensive care; Risk factors

Indexed keywords

ARTICLE; CANDIDA TROPICALIS; CENTRAL VENOUS CATHETERIZATION; CROSS INFECTION; ENTEROBACTER; EPIDEMIOLOGY; FEMALE; HUMAN; INFANT; INTENSIVE CARE; ISOLATION AND PURIFICATION; KLEBSIELLA PNEUMONIAE; MALE; MICROBIOLOGY; PRESCHOOL CHILD; STAPHYLOCOCCUS EPIDERMIDIS;

CANDIDA TROPICALIS; CATHETERIZATION, CENTRAL VENOUS; CHILD, PRESCHOOL; CROSS INFECTION; ENTEROBACTER; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; INFANT; INTENSIVE CARE UNITS, PEDIATRIC; KLEBSIELLA PNEUMONIAE; MALE; STAPHYLOCOCCUS EPIDERMIDIS;

EID: 36448974921     PISSN: 18075932     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1807-59322007000500002     Document Type: Article

References (26)

1. Centers for Disease Control and Prevention. Guidelines for the prevention of intravascular catheter-related infection. MMWR 2002;51(RR-10):1-29
2. De Jonge RCJ, Polderman KH, Gemke RJBJ. Central venous catheter use in the pediatric patient: mechanical and infectious complications. Pediatr Crit Care Med 2005;6:329-339
3. Pollock E, Ford-Jones EL, Corey M, Barker MD, Mindorff CM, Gold R et al. Use of the Pediatric Risk of Mortality score to predict nosocomial infection in a pediatric intensive care unit. Crit Care Med 1991;19:160-165
4. Arantes A, Carvalho ES, Medeiros EAS, Farhat CK, Mantese OC. Pediatric risk of mortality and hospital infection. Infect Control Hosp Epidemiol 2004;25:783-785
5. Pearson ML, Hospital Infection Control Practices Advisory Committee (HICPAC). Guideline for prevention of intravascular-device-related infections. Infect Control Hosp Epidemiol 1996;17:438-473
6. National Nosocomial Infections Surveillance System. National Nosocomial Infections Surveillance (NNIS) System report, data summary from January 1992 to June 2002, issued August 2002. Am J Infect Control 2002;30:458-475
7. Richards MJ, Edwards JR, Culver DH, Gaynes RP, National Nosocomial Infection Surveillance System. Nosocomial infections in pediatric intensive care units in the United States. Pediatrics 1999;103:804-810
8. Grohskopf LA, Sinkowitz-Cochran RL, Garrett DO, Sohn AH, Levine GL, Siegel JD et al. A national point-prevalence survey of pediatric intensive care unit-acquired infections in the United States. J Pediatr 2002;140:432-438
9. Abramczyk, ML, Carvalho, WB, Carvalho, ES, Medeiros, EAS. Nosocomial infection in a pediatric intensive care unit in a developing country. Braz J Infect Dis 2003;7:375-380
10. Slonim AD, Kurtines HC, Sprague BM, Singh-Naz N. The cost associated with nosocomial bloodstream infections in the pediatric intensive care unit. Pediatr Crit Care Med 2001;2:170-174
11. Yogaraj JS, Elward AM, Fraser VJ. Rate, risk factors, and outcomes of nosocomial primary bloodstream infection in pediatric intensive care unit patients. Pediatrics 2002;110: 481-485
12. Sznajder JI, Zveibil FR, Bitterman H, Weiner P, Bursztein S. Central vein catheterization: failure and complication rates by three percutaneous approaches. Arch Intern Med 1986;146:259-61
13. Coopersmith CM, Rebmann TL, Zack JE, Ward MR, Corcoran RM, Schallom ME et al. Effect of an educational program on decreasing catheter-related bloodstream infections in surgical intensive care unit. Crit Care Med 2002;30:59-64
14. Merrer J, De Jonghe B, Golliot F, Lefrant JY, Raffy B, Barre E et al. Complications of femoral and subclavian venous catheterization in critically ill patients: a randomized controlled trial. JAMA 2001;286:700-707
15. Heard SO, Wagle M, Vijayakumar E, Mclean S, Brueggemann A, Napolitano LM et al. Influence of triple-lumen central venous catheters coated with chlorhexidine and silver sulfadiazine on the incidence of catheter-related bacteremia. Arch Intern Med 1998;158:81-87
16. American Heart Association. Vascular access. In: Hazinski MF ed. PALS provider manual. EUA, 2002.
17. Maki DG: Infections caused by intravascular devices used for infusion therapy: pathogenesis, prevention, and management. In: Bistro AI, Waldvogel FA eds. Infections associated with indwelling medical devices, Second Edition. Washington: ASM Press, 1994
18. Odetola FO, Moler FW, Dechert RE, VanDerElzen K, Chenoweth C. Nosocomial catheter-related bloodstream infections in a pediatric intensive care unit: risk and rates associated with various intravascular technologies. Pediatr Crit Care Med 2003;4:432-436
19. Kacica MA, Horgan MJ, Ochoa L, Sandler R, Lepow ML, Venezia RA. Prevention of Gram-positive sepsis in neonatos wighting less than 1500g. J Pediatr 1994;125:253-258
20. Spafford PS, Sinkin RA, Cox C, Reubens L, Powell KR. Prevention of central venous catheter-related coagulase-negative staphylococcal sepsis in neonates. J Pediatr 1994;125:259-263
21. Centers for Disease Control and Prevention (CDC). Recommendations for preventing the spread of vancomicyn resistance. Recommendation of the Hospital Infection Control Practices Advisory Committee (HICPAC). MMWR 1995; RR12, 44pp
22. Wagner SJ, Friedman LI, Dodd RY. Transfusion-associated bacterial sepsis. Clin Microbiol Rev 1994;7:290-302
23. Yeung CY, Lee HC, Huang FY, Wang CS. Sepsis during total parenteral nutrition: exploration of risk factors an determination of effectiveness of peripherally inserted central venous catheters. Pediatr Infect Dis J 1998;17:135-142
24. Randolph AG, Cook DJ, Gonzáles CA, Andrew M. Benefit of heparin in central venous and pulmonary artery catheters: a meta-analysis of randomized controlled trials. Chest 1998;113:165-171
25. Pollack MM, Ruttimann UE, Getson PR. Pediatric risk of mortality (PRISM) score. Crit Care Med 1988;16:1110-1116
26. Singh-Naz N, Sprague BM, Patel KM, Pollack MM. Risk assessment and standardized nosocomial infection rate in critically ill children. Crit Care Med 2000;28:2069-2075